Condition: Solid Tumors · Non-small Cell Lung Cancer · Renal Cell Carcinoma · Sponsor: 3D Medicines (Sichuan) Co., Ltd.
This is an open-label, multi-center study of Phase Ib/II study to assess the efficacy and safety of Envafolimab combinded with Lenvatinib in the treatment of subjects with advanced solid tumors. The primary hypothesis of this study is that subjects will have a better objective response rate (ORR) when treated with Envafolimab plus Lenvatinib than SOC.
This description comes directly from the study's public registry record.
siying xu · +86(10) 64882533 · siying.xu@3d-medicines.com
Always discuss trial participation with your own doctor first.
| The First Affiliated Hospital of Bengbu Medical College | Bengbu, Anhui, China | Recruiting |
| The Seventh Medical Center of the PLA General Hospital | Beijing, Beijing Municipality, China | Recruiting |
| Beijing Hospital | Beijing, Beijing Municipality, China | Not Yet Recruiting |
| Fujian Medical University Union Hospital | Fuzhou, Fujian, China | Not Yet Recruiting |
| Zhongshan Hospital,Fudan University(Xiamen Branch) | Xiamen, Fujian, China | Not Yet Recruiting |
| Dongguan People's Hospital | Dongguan, Guangdong, China | Recruiting |
| Zhujiang Hospital of Southern Medical University | Guangzhou, Guangdong, China | Recruiting |
| The Fifth Affiliated Hospital Sun Yat-Sen University | Zhuhai, Guangdong, China | Recruiting |
| Harbin Medical University Cancer Hospital | Haerbin, Heilongjiang, China | Not Yet Recruiting |
| The First Affiliated Hospital of Zhengzhou University | Zhengzhou, Henan, China | Recruiting |
| The Second Affiliater Hospital of Nanchang University | Nanchang, Jiangxi, China | Not Yet Recruiting |
| THE First Hospital of Jilin University | Changchun, Jilin, China | Not Yet Recruiting |
+ 11 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05024214